Literature DB >> 11900678

Differentiating pancreatic cancer from pseudotumorous chronic pancreatitis.

Tony E Yusuf1, Manoop S Bhutani.   

Abstract

The differentiation between pancreatic carcinoma and pseudotumorous pancreatitis continues to be a challenge. Several diagnostic imaging and endoscopic modalities can assist in making the differentiation, but the accuracy of each method varies. Radiologic imaging techniques include transabdominal ultrasound, computed tomography, magnetic resonance imaging, magnetic resonance cholangiopancreatography, and positron emission tomography. Endoscopic techniques include endoscopic ultrasonography, intraductal ultrasonography, and endoscopic retrograde cholangiopancreatography with brush cytology of pancreatobiliary strictures, endoscopic forceps biopsy, and analysis of pancreatic juices for malignant cells. Tumor markers appear to be promising, but further studies are needed to define the role of these markers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900678     DOI: 10.1007/s11894-002-0050-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  37 in total

1.  Pancreatography in chronic pancreatitis: international definitions.

Authors:  A T Axon; M Classen; P B Cotton; M Cremer; P C Freeny; W R Lees
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

2.  Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma.

Authors:  D Becker; D Strobel; T Bernatik; E G Hahn
Journal:  Gastrointest Endosc       Date:  2001-06       Impact factor: 9.427

3.  Pancreatic diseases: evaluation with MR cholangiopancreatography.

Authors:  E Ueno; Y Takada; I Yoshida; J Toda; T Sugiura; F Toki
Journal:  Pancreas       Date:  1998-04       Impact factor: 3.327

4.  The double duct sign in patients with malignant and benign pancreatic lesions.

Authors:  M Menges; M M Lerch; M Zeitz
Journal:  Gastrointest Endosc       Date:  2000-07       Impact factor: 9.427

5.  Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles.

Authors:  K Koito; T Namieno; T Nagakawa; K Morita
Journal:  AJR Am J Roentgenol       Date:  1997-11       Impact factor: 3.959

6.  EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.

Authors:  H R Mertz; P Sechopoulos; D Delbeke; S D Leach
Journal:  Gastrointest Endosc       Date:  2000-09       Impact factor: 9.427

Review 7.  Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.

Authors:  M Ebert; L Schandl; R M Schmid
Journal:  Dig Dis       Date:  2001       Impact factor: 2.404

8.  Diagnosis of pancreatic carcinoma: role of FDG PET.

Authors:  M T Keogan; D Tyler; L Clark; M S Branch; V G McDermott; D M DeLong; R E Coleman
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

9.  The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease.

Authors:  A Rajput; T A Stellato; P F Faulhaber; H J Vesselle; F Miraldi
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

10.  Radical pancreatoduodenectomy for misdiagnosed pancreatic mass.

Authors:  C D Smith; K E Behrns; J A van Heerden; M G Sarr
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.